Wellington Management Group
TARS icon

Wellington Management Group’s Tarsus Pharmaceuticals TARS Stock Holding History

Wellington Management Group’s Portfolio TARS Stock Details TARS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.53M Buy
40,202
+24,117
+150% +$1.54M ﹤0.01% 1576
2026
Q1 		$1.13M Sell
16,085
-693
-4% -$48.4K ﹤0.01% 1652
2025
Q4 		$1.37M Sell
16,778
-571
-3% -$42.6K ﹤0.01% 1666
2025
Q3 		$1.03M Sell
17,349
-106,287
-86% -$5.23M ﹤0.01% 1771
2025
Q2 		$5.01M Buy
123,636
+7,526
+6% +$339K ﹤0.01% 1381
2025
Q1 		$5.96M Sell
116,110
-20,685
-15% -$1.02M ﹤0.01% 1336
2024
Q4 		$7.57M Sell
136,795
-8,552
-6% -$388K ﹤0.01% 1265
2024
Q3 		$4.78M Buy
145,347
+18,019
+14% +$506K ﹤0.01% 1340
2024
Q2 		$3.46M Buy
127,328
+15,906
+14% +$535K ﹤0.01% 1397
2024
Q1 		$4.05M Buy
+111,422
New +$3.28M ﹤0.01% 1371

Other funds holding TARS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Wellington Management Group's TARS Position: Q2 2026 in Review

Wellington Management Group increased its Tarsus Pharmaceuticals (TARS) stake by 150% in Q2 2026, buying an estimated $1.54M and bringing the position to 40,202 shares worth $2.53M. The position accounts for ﹤0.01% of the portfolio, ranked #1576.

Wellington Management Group first reported a position in TARS in Q1 2024 and has held it in 10 quarters since. The position peaked at $7.57M in Q4 2024. 257 funds tracked by Wall St. Rank hold TARS as of Q2 2026.

  • Wellington Management Group held 40,202 shares of Tarsus Pharmaceuticals worth $2.53M as of Q2 2026.
  • Wellington Management Group bought 24,117 Tarsus Pharmaceuticals shares in Q2 2026, an estimated $1.54M.
  • Tarsus Pharmaceuticals made up ﹤0.01% of Wellington Management Group's portfolio in Q2 2026, its #1576 holding.
  • Wellington Management Group first reported a position in Tarsus Pharmaceuticals in Q1 2024 and has held it in 10 quarters since.
  • Wellington Management Group's Tarsus Pharmaceuticals position peaked at $7.57M in Q4 2024.
  • 257 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q2 2026.

Based on Wellington Management Group's 13F filing for Q2 2026, filed 14 Aug 2026.